Abiraterone Acetate 250mg Tablets

Abiraterone Acetate 250mg is a hormone-synthesis inhibitor used with a corticosteroid for advanced prostate cancer. It forms part of treatment alongside continued medical or surgical testosterone suppression.
Take conventional tablets on an empty stomach: no food for at least 2 hours before and 1 hour after the dose. Swallow whole with water. Take the accompanying prednisone or prednisolone on its scheduled plan. Food instructions for other abiraterone formulations do not replace this fasting interval.
Abiraterone acetate is converted to abiraterone, which inhibits CYP17 and reduces androgen synthesis in the testes, adrenal glands and tumour tissue.
Fluid retention, high blood pressure, low potassium, fatigue and liver-enzyme increases can occur. Severe weakness, palpitations, jaundice or increasing breathlessness needs assessment.
Blood pressure, potassium and fluid status are checked regularly, with closer liver monitoring early in treatment. Do not abruptly stop the accompanying steroid. Strong enzyme inducers and some heart or psychiatric medicines can interact.
Suppressing androgen production beyond the testes adds another level of hormonal control and can delay disease progression in eligible advanced prostate cancer.
CYP17 inhibition can increase mineralocorticoid effects, causing hypertension, fluid retention and low potassium. Prednisone or prednisolone helps limit this imbalance.
Food can markedly increase exposure to conventional tablets, making absorption and adverse effects less predictable.
No. Resume the usual daily dose the following day. Several missed days of abiraterone or the steroid require a specific restart plan.
The body normally increases cortisol during stress. Temporary steroid adjustment may be needed because treatment limits this response.
CYP17: an enzyme involved in androgen synthesis. Mineralocorticoid effect: salt- and water-retaining hormonal activity. Castration-resistant: progressing despite castrate testosterone levels.; AR: Abiraterone Acetate 250mg أقراص; FR: Abiraterone Acetate 250mg comprimés; PT: Abiraterone Acetate 250mg comprimidos; ES: Abiraterone Acetate 250mg comprimidos; RU: Abiraterone Acetate 250mg таблетки; ID: Abiraterone Acetate 250mg tablet; VI: Abiraterone Acetate 250mg viên nén; MS: Abiraterone Acetate 250mg tablet; TL: Abiraterone Acetate 250mg mga tableta; ZH-SG: Abiraterone Acetate 250mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Abiraterone Acetate 250mg Tablets under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Abiraterone Acetate 250mg Tablets